Rep. John R. Moolenaar

Maddy summaryThe FOCA Act of 2023 requires federal agencies to stop mandating or banning contractor agreements with labor organizations (like union contracts) in construction project bids and contracts. It directly affects federal contractors, subcontractors, and agencies managing construction projects funded by the government. The bill prohibits favoring or penalizing contractors based on their labor affiliation status, aiming to promote fair competition and reduce costs. It also mandates updates to federal contracting rules within 60 days of enactment to implement these changes.

Maddy summaryThis bill codifies and expands existing U.S. sanctions targeting Chinese entities involved in fentanyl-related activities. It authorizes the President to impose financial sanctions on foreign persons - including Chinese government entities, ports, ships, manufacturers, and online marketplaces - that facilitate the international flow of illicit synthetic narcotics or their precursors. Key provisions include blocking U.S. financial transactions with targeted entities, requiring congressional reporting on enforcement, and excluding intelligence/law enforcement activities from sanctions. The bill directly affects Chinese entities operating in Hong Kong, Macau, or mainland China that contribute to fentanyl proliferation, with sanctions applying to property or transactions within U.S. jurisdiction.

Maddy summaryHR 10459 establishes a federal Joint Task Force to Counter Illicit Synthetic Narcotics (JTF-ISN) to coordinate agency efforts against synthetic opioid trafficking. The task force, led by a presidentially appointed Director reporting to the Attorney General, includes members from Justice (DEA, FBI), Treasury (FinCEN, IRS), Homeland Security (CBP, ICE), State, Commerce, Defense, and intelligence agencies. It requires regular congressional reports on operations, funding needs, and efforts to disrupt trafficking networks - particularly those linked to foreign entities like China - while explicitly limiting the task force to targeting large-scale trafficking, not personal use or low-level dealing. The bill does not create new agency powers but mandates better interagency coordination to address the opioid crisis through strategic operations and information sharing.

Maddy summaryThis bill requires Chinese shipping companies to properly declare fentanyl precursors and related chemicals on all shipments to the U.S., with strict customs reporting rules. It imposes civil penalties of up to $250,000 or 0.025% of a vessel’s cargo value for non-compliance, doubling for falsified records and escalating for repeated violations. The penalties collected fund U.S. drug enforcement efforts targeting fentanyl trafficking. It directly affects Chinese entities (including those with significant Chinese ownership) involved in shipping these chemicals to the U.S. or cooperating jurisdictions.

Maddy summaryHR 10127, the Restoring Trade Fairness Act, would suspend China's normal trade relations status, requiring higher tariffs on Chinese imports. The bill mandates minimum 35% duties for most Chinese goods and 100% for specific listed items, with these rates phased in over 5 years. It also establishes tariff-rate quotas for products imported only from China and creates a trust fund to compensate U.S. producers affected by Chinese retaliation. This policy would shift Chinese imports from standard lower tariff rates to higher rates typically applied to countries without normal trade relations status.

Maddy summaryThis bill extends Medicare payment adjustments for physicians and other practitioners through 2025 instead of ending in 2024. It specifically adds a 4.73% payment increase for services provided between January 1, 2025, and January 1, 2026. The legislation modifies existing Medicare payment rules to stabilize practice revenues during transition periods. It directly affects doctors and healthcare providers who bill Medicare for patient services. The key change is the extended timeframe and the defined 4.73% rate for the 2025-2026 period.

Maddy summaryThe Pharmacists Fight Back Act (HR 9096) sets new rules for Pharmacy Benefits Managers (PBMs) working with federal health care programs like Medicare Part D and Medicaid. It requires PBMs to reimburse in-network pharmacies at a rate covering the drug's actual cost plus a small fee (capped at $25), and to reduce patient cost-sharing by at least 80% of rebates received from drug manufacturers. The bill bans PBMs from steering patients to specific pharmacies, charging patients more than pharmacies are paid, or using rebates to lower pharmacy payments after claims are processed. It also mandates public reporting of drug pricing data to improve transparency, ensuring patients and pharmacies receive fairer treatment under federal health programs.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.

Maddy summaryThis bill prohibits the Department of Homeland Security (DHS) from using federal funds to purchase batteries produced by specific Chinese companies starting October 1, 2027. It directly affects DHS procurement by banning purchases from entities like CATL, BYD, and Envision Energy, and any successors to these companies. The law defines "produced by" to include both final assembly and majority component sourcing, ensuring the restriction covers broader supply chains. Waivers are possible only if DHS certifies no national security risks, no alternatives exist, or purchases are for research - requiring congressional notification. The policy aims to reduce reliance on batteries from entities linked to national security concerns.

Maddy summaryThis bill would impose increasing tariffs on Chinese-made drones (starting at 30% and rising to 45% over four years) to reduce reliance on Chinese drone manufacturers. It establishes a fund using tariff revenue to provide grants for first responders, farmers, ranchers, and critical infrastructure providers to purchase secure drones not made in China or by Chinese companies. The legislation also requires documentation for drones entering the US to verify they don't contain components made in China. The bill directly affects those who currently rely on Chinese-made drones for critical operations, as over 90% of drones used by first responders are made in China. Its goal is to strengthen national security by reducing dependence on Chinese drone technology for essential services.